9336 J . Org. Chem., Vol. 61, No. 26, 1996
Yoon et al.
(4 H, m); 2.17 (4 H, m); 2.52 (16 H, m); 2.69 (16 H, m); 2.93 (4
H, t); 3.92 (4 H, br s); 4.24 (8 H, t, J ) 7.8 Hz); 4.27 (4 H, t);
4.89 (8 H, m); 5.82 (4H, d, J ) 6.9 Hz); 5.85 (4 H, s); 5.89 (4H,
d, J ) 6.9 Hz); 6.82 (4 H, s); 6.88 (2 H, s); 6.94 (2 H, s); 7.16
(16 H, m); 7.23 (24 H, m); FAB MS, m/ e (2313.0, M+) 2314.0
(40), 2208.3 (100). Anal. Calcd for C149H140O24‚2H2O: C,
76.13; H, 6.17. Found: C, 76.14; H, 5.99.
70 mg (0.18 mmol) more of 1,3-propanediol ditosylate was
added. After stirring at 75 °C for another 24 h, the mixture
was poured into 50 mL of 5% NaCl (aq). The precipitate that
formed was filtered, washed with methanol, and chromato-
graphed on a preparative TLC plate with CHCl3 to give 46
mg (46%) of 6 (empty): 1H NMR δ 1.99 (12 H, br s); 2.22 (2 H,
m); 2.51 (16 H, m); 2.67 (16 H, m); 3.90 (12 H, m); 4.18 (4 H,
t, J ) 7.1 Hz); 4.30 (8 H, d, J ) 7.8 Hz); 4.81 (8 H, t, J ) 7.8
Hz); 5.78 (4 H, d, J ) 7.3 Hz); 5.82 (4 H, d, J ) 7.3 Hz); 6.82
(8 H, m); 7.12 (16 H, m); 7.23 (24 H, m); FAB MS, m/ e (2234.9,
M+), 2237.5 (100). Anal. Calcd for C143H134O24‚2H2O: C,
75.57; H, 6.12. Found: C, 75.62; H, 6.09.
8,9,10,11,39,40,41,42-Octa h yd r o-1,18,26,28,53,55,63,78-
octaph en eth yl-34,47-(epoxybu tan oxy)-20,24:57,61-dim eth -
a n o-2,52:17,29-d im et h en o-3,51,16,30-(m et h yn oxyet h a n -
oxym et h yn o)-1H ,18H ,26H ,28H ,53H ,55H -b is[1,3]b en zo-
d ioxocin o[9,8-d :9′,8′-d ′]b is[1,3]b e n zod ioxocin o[9′,10′:
17,18;10′′,9′′:25,26][1,3,6,11,14,16,19, 24]octa oxa cycloh exa -
cosin o[4,5-j:13,12-j′]bis[1,3]ben zod ioxocin , Ster eoisom er
5.NMP . P r oced u r e C. A mixture of diol 2 (100 mg, 0.045
mmol), 50 mL of NMP, 1 g of Cs2CO3, and 33 mg (0.09 mmol)
of 1,2-ethanediol ditosylate was stirred at 75 °C for 24 h, and
a second portion of 66 mg (0.18 mmol) of 1,2-ethanediol
ditosylate was added. After stirring at 75 °C for another 24
h, the solvent was removed in vacuo and the residue was
dissolved in CHCl3. The remaining solids were filtered
through a 1 cm pad of Celite and the solvent was rotary
evaporated, concentrated to ∼3 mL, and poured into 100 mL
of methanol. The precipitate that formed was filtered and
chromatographed on a preparative TLC plate with CHCl3 to
give 47 mg (45%) of 5.NMP: 1H NMR δ -0.93 (2 H, q); -0.89
(3 H, s); -0.72 (2 H, t); 1.99 (12 H, m); 2.51 (16 H, m); 2.67 (16
H, m); 3.95 (8 H, br s); 4.06 (4 H, br s); 4.21 (4 H, d, J ) 7.0
Hz); 4.42 (4 H, d, J ) 7.0 Hz); 4.54 (4 H, s); 4.81 (8 H, m); 6.05
(4H, d, J ) 7.3 Hz); 6.80 (2 H, s); 6.83 (4 H, s); 6.87 (2 H, s);
7.12 (16 H, m); 7.24 (24 H, m); FAB MS, m/ e (2320.0, M+)
2320.2, (100). Anal. Calcd for C147H141NO25: C, 76.05; H, 6.12.
Found: C, 76.09; H, 6.06.
5.DMSO. Application of procedure C to 100 mg (0.045
mmol) of diol 2, 15 mL of DMSO, 1 g of Cs2CO3, and 99 mg
(0.27 mmol) of 1,2-ethanediol ditosylate gave 42 mg (41%) of
5.DMSO after preparative TLC: 1H NMR δ -0.48 (6 H, s);
2.02 (12 H, br s); 2.47 (16 H, m); 2.68 (16 H, m); 3.95 (8 H, br
s); 4.04 (4 H, br s); 4.12 (4 H, d, J ) 7.1 Hz); 4.28 (4 H, d, J )
7.1 Hz); 4.54 (4 H, s); 4.84 (8 H, m); 5.86 (8 H, t, J ) 7.6 Hz);
6.78 (2 H, s); 6.85 (4 H, s); 6.89 (2 H, s); 7.17 (16 H, m); 7.23
(24 H, m); FAB MS, m/ e (2298.9, M+) 2301.4 (100), 2222.8
(30). Anal. Calcd for C144H138O25S: C, 75.18; H, 6.05.
Found: C, 75.08; H, 6.05.
5.DMA. Application of procedure C to 100 mg (0.045
mmol) of diol 2, 20 mL of DMA, 1 g of Cs2CO3, and 99 mg
(0.27 mmol) of 1,2-ethanediol ditosylate gave 44 mg (42%) of
5.DMA after preparative TLC: 1H NMR δ -1.67 (3 H, s);
-0.56 (3 H, s); 1.64 (3 H, s); 1.96 (12 H, m); 2.48 (16 H, m);
2.67 (16 H, m); 3.92 (8 H, t, br s); 4.01 (4 H, br s); 4.14 (4 H,
d, J ) 7.1 Hz); 4.45 (4 H, d, J ) 7.1 Hz); 4.65 (4 H, s); 4.83 (8
H, m); 5.81 (8H, t, J ) 6.4 Hz); 6.75 (2 H, s); 6.83 (4 H, s); 6.89
(2 H, s); 7.16 (16 H, m); 7.22 (24 H, m); FAB MS, m/ e (2308.0,
M+), 2309.7 (100). Anal. Calcd for C146H141NO25: C, 75.92;
H, 6.15. Found: C, 75.87; H, 5.96.
5.1,4-Me2C6H4. Application of procedure B to 30 mg (0.013
mmol) of 5.DMA and 1 mL of p-xylene gave after preparative
TLC with CHCl3 25 mg (88%) of 5.1,4-Me2C6H4: 1H NMR δ
-1.93 (6 H, s); 1.21 (4 H, m); 2.10 (8 H, m); 2.52 (16 H, m);
2.70 (16 H, m); 3.09 (4 H, t); 4.03 (4 H, br s); 4.11 (4 H, d, J )
6.9 Hz); 4.17 (4 H, d, J ) 6.9 Hz); 4.18 (4 H, s); 4.21 (4 H, t);
4.86 (8 H, m); 5.69 (4H, d, J ) 6.9 Hz); 5.78 (4H, d, J ) 6.9
Hz); 5.97 (4 H, s); 6.82 (2 H, s); 6.85 (2 H, s); 6.94 (4 H, s); 7.17
(16 H, m); 7.23 (24 H, m); FAB MS, m/ e (2327.0, M+), 2329.7
(100), 2224.0 (90). Anal. Calcd for C150H142O24: C, 77.37; H,
6.15. Found: C, 77.68; H, 5.98.
6.NMP . Application of procedure C to 100 mg (0.045
mmol) of diol 2, 50 mL of NMP, 1 g of Cs2CO3, and 35 mg (0.09
mmol) of 1,3-propanediol ditosylate (first portion) and 70 mg
(0.18 mmol) of 1,3-propanediol ditosylate (second portion) gave
after preparative TLC with CHCl3 67 mg (64%) of 6.NMP:
1H NMR δ -0.90 (3 H, s); -0.82 (2 H, q); -0.60 (2 H, t); 1.98
(12 H, br s); 2.22 (2 H, m); 2.48 (16 H, m); 2.65 (16 H, m); 3.98
(12 H, m); 4.18 (4 H, t, J ) 7.1 Hz); 4.21 (4 H, d, J ) 7.6 Hz);
4.41 (4 H, d, J ) 7.6 Hz); 4.85 (8 H, t, J ) 7.8 Hz); 5.81 (8 H,
t, J ) 7.3 Hz); 6.85 (8 H, m); 7.13 (16 H, m); 7.23 (24 H, m);
FAB MS, m/ e (2334.0, M+), 2336.0 (100). Anal. Calcd for
C148H143NO25: C, 76.11; H, 6.17. Found: C, 76.17; H, 6.17.
6.DMSO. Application of procedure C to 100 mg (0.045
mmol) of diol host 2, 50 mL of DMSO, 1 g of Cs2CO3, and 105
mg (0.27 mmol) of 1,3-propanediol ditosylate gave 62 mg (60%)
of 6.DMSO after preparative TLC with CHCl3: 1H NMR δ
-0.51 (6 H, s); 2.03 (12 H, br s); 2.25 (2 H, m); 2.50 (16 H, m);
2.69 (16 H, m); 3.94 (12 H, m); 4.19 (4 H, t); 4.21 (8 H, t); 4.84
(8 H, t, J ) 7.8 Hz); 5.83 (4 H, d, J ) 7.3 Hz); 5.88 (4 H, d, J
) 7.3 Hz); 6.84 (8 H, m); 7.15 (16 H, m); 7.24 (24 H, m); FAB
MS, m/ e (2312.9, M+), 2315.4 (100). Anal. Calcd for
C145H140O25S: C, 75.24; H, 6.10. Found: C, 75.31; H, 6.10.
6.DMA. Application of procedure C to 100 mg (0.045
mmol) of diol 2, 50 mL of DMA, 1 g of Cs2CO3, and 105 mg
(0.27 mmol) of 1,3-propanediol ditosylate gave 67 mg (64%) of
6.DMA after preparative TLC with CHCl3: 1H NMR δ -1.68
(3 H, s); -0.53 (3 H, s); 2.01 (12 H, br s); 2.25 (2 H, m); 2.49
(16 H, m); 2.68 (16 H, m); 3.91 (12 H, m); 4.20 (8 H, d, J ) 7.2
Hz); 4.39 (4 H, d, J ) 7.4 Hz); 4.84 (8 H, t, J ) 7.9 Hz); 5.81
(4 H, d, J ) 7.5 Hz); 5.84 (4 H, d, J ) 7.5 Hz); 6.82 (2 H, s);
6.84 (4 H, s); 6.87 (2 H, s); 7.15 (16 H, m); 7.24 (24 H, m );
FAB MS, m/ e (2322.0, M+), 2323.7 (100). Anal. Calcd for
C147H143NO25: C, 75.98; H, 6.20. Found: C, 76.16; H, 6.03.
6.1,4-Me2C6H4. Application of procedure B to 30 mg (0.013
mmol) of 6 (empty) and 1 mL of p-xylene gave after preparative
TLC with CHCl3 27 mg (90%) of 6.1,4-Me2C6H4: 1H NMR δ
-2.01 (6 H, s); 1.67 (4 H, br s); 1.97 (2 H, m); 2.09 (8 H, br s);
2.52 (16 H, m); 2.70 (16 H, m); 3.36 (4 H, t, J ) 6.9 Hz); 3.66
(4 H, br s); 4.12 (8 H, hidden); 4.12 (4 H, d, J ) 6.9 Hz); 4.18
(4 H, d, J ) 6.9 Hz); 4.87 (8 H, t, J ) 7.8 Hz); 5.71 (8 H, dd,
J ) 7.0 Hz); 5.94 (4H, s); 6.85 (4 H, s); 6.94 (4 H, s); 7.16 (16
H, m); 7.23 (24 H, m); FAB MS, m/ e (2341.0, M+), 2342 (100),
2236 (50). Anal. Calcd for C151H144O24: C, 77.41; H, 6.20.
Found: C, 77.29; H, 6.12.
8,9,10,11,40,41,42,43-Octa h yd r o-1,18,26,28,54,56,64,81-
octaph en eth yl-34,48-(epoxybu tan oxy)-20,24:58,62-dim eth -
a n o-2,53:17,29-d im et h en o-3,52,16,30-(m et h yn oxyb u t a n -
oxym e t h yn o)-1H ,18H ,26H ,28H ,39H ,54H ,56H -b is[1,3]-
b e n zod ioxocin o[9,8-d :9′,8′-d ′]b is[1,3]b e n zod ioxocin o-
[9′,10′:4,5;10′′,9′′:12,13][1,3,6,11,14,16,19,25]octa oxa cyclo-
h ep ta cosin o[17,18-j:27,26-j′]bis[1,3]ben zod ioxocin , Ste-
r eoisom er 8.CHCl3. A mixture of 100 mg (0.045 mmol) of
diol 2, 50 mL of NMP, 1 g of Cs2CO3, and 36 mg (0.09 mmol)
of 1,5-pentanediol dimesylate was stirred at 25 °C for 5 h, and
then the temperature was raised to 50 °C and the mixture
stirred for 24 h. The solution was stirred for another 24 h
after the addition of 36 mg (0.09 mmol) of 1,5-pentanediol
dimesylate. The product was isolated as in procedure A to
give after preparative TLC with CHCl3 81 mg (79%) of
8.CHCl3: 1H NMR δ 1.82 (6 H, m); 1.97 (12 H, br s); 2.49 (16
H, m); 2.68 (16 H, m); 3.88 (4 H, m); 3.97 (12 H, br s); 4.20 (4
H, d, J ) 7.0 Hz); 4.23 (4 H, d, J ) 7.0 Hz); 4.83 (8 H, m); 5.81
(4 H, d, J ) 6.9 Hz); 5.86 (4 H, d, J ) 6.9 Hz); 6.80 (2 H, s);
6.82 (2 H, s); 6.84 (4 H, s); 7.17 (16 H, m); 7.23 (24 H, m); FAB
8,9,10,11,39,40,41,42-Octa h yd r o-1,18,26,28,53,55,63,79-
octaph en eth yl-34,47-(epoxybu tan oxy)-20,24:57,61-dim eth -
a n o-2,52:17,29-d im eth en o-3,51,16,30-(m eth yn oxyp r op a n -
oxym e t h yn o)-1H ,l8H ,26H ,28H ,53H ,55H -b is[1,3]b e n zo-
d ioxocin o[9,8-d :9′,8′-d ′]b is[1,3]b e n zod ioxocin o[9′,10′:
17,18;10′′,9′′:25,26][1,3,6,11,14,16,19, 24]octa oxa cycloh exa -
cosin o[4,5-j:13,12-j′]bis[1,3]ben zod ioxocin , Ster eoisom er
6 (Em p ty). P r oced u r e D. A mixture of diol 2 (100 mg (0.045
mmol), 10 mL of HMPA, 1 g of Cs2CO3, and 35 mg (0.09 mmol)
of 1,3-propanediol ditosylate was stirred at 75 °C for 24 h, and